Integer (NYSE:ITGR) Stock Rating Upgraded by Freedom Capital

Integer (NYSE:ITGR) was upgraded by research analysts at Freedom Capital to a “strong-buy” rating in a report released on Wednesday,Zacks.com reports.

ITGR has been the topic of a number of other reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Integer in a research report on Thursday, June 18th. Citigroup boosted their price objective on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a report on Wednesday, July 8th. KeyCorp reaffirmed an “overweight” rating and issued a $104.00 target price on shares of Integer in a research note on Tuesday. Truist Financial increased their target price on shares of Integer from $97.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, July 16th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $97.00 target price (up from $87.00) on shares of Integer in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $97.00.

Integer Stock Up 0.8%

Shares of Integer stock opened at $97.33 on Wednesday. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. Integer has a 12 month low of $62.00 and a 12 month high of $115.51. The business has a fifty day simple moving average of $92.26 and a 200 day simple moving average of $88.08. The stock has a market cap of $3.31 billion, a PE ratio of 24.27, a price-to-earnings-growth ratio of 2.30 and a beta of 0.64.

Integer (NYSE:ITGR) last released its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a net margin of 7.64% and a return on equity of 12.83%. The company had revenue of $439.58 million during the quarter, compared to analyst estimates of $426.48 million. During the same period in the previous year, the company posted $1.31 EPS. The company’s quarterly revenue was up .5% compared to the same quarter last year. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. Research analysts predict that Integer will post 6.04 EPS for the current year.

Institutional Trading of Integer

Hedge funds and other institutional investors have recently modified their holdings of the company. Heartland Advisors Inc. grew its holdings in shares of Integer by 506.8% in the 4th quarter. Heartland Advisors Inc. now owns 242,715 shares of the medical equipment provider’s stock valued at $19,036,000 after acquiring an additional 202,715 shares in the last quarter. WINTON GROUP Ltd acquired a new stake in shares of Integer in the fourth quarter valued at about $4,836,000. Jennison Associates LLC bought a new stake in Integer during the fourth quarter worth about $1,036,000. Kestrel Investment Management Corp bought a new stake in Integer during the fourth quarter worth about $5,933,000. Finally, William Blair Investment Management LLC boosted its position in Integer by 70.1% during the fourth quarter. William Blair Investment Management LLC now owns 468,377 shares of the medical equipment provider’s stock valued at $36,735,000 after purchasing an additional 192,956 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.